ThreeD Capital Inc. Announces Securities Purchase Agreement with Sariel Diagnostics Corp.

TORONTO, July 24, 2024 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK) (OTCQB:IDKFF), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce a proposed Securities Purchase Agreement (the “Agreement”) with Sariel Diagnostics Corp. (“Sariel”), a privately held corporation existing under the laws of the Province of British Columbia. Per the terms of the Agreement, ThreeD will acquire 3,200,000 common shares of Sariel at a price of $0.05 per share. In consideration, ThreeD will issue an aggregate of 200,000 common shares of the Company at a deemed price of $0.80 per common share.  

Read more at globenewswire.com